Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII
Clinical trial NCT03818893 · UNKNOWN
Trial details
- NCT number
- NCT03818893
- Sponsor
- Osaka University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-12-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.